Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Hollister Biosciences Inc (HSTRF)

Hollister Biosciences Inc (HSTRF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade HSTRF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2750 +10.73%
on 02/26/21
0.4200 -27.50%
on 02/10/21
-0.0049 (-1.58%)
since 02/03/21
3-Month
0.0900 +238.33%
on 12/08/20
0.4200 -27.50%
on 02/10/21
+0.1995 (+190.00%)
since 12/03/20
52-Week
0.0250 +1,118.00%
on 04/06/20
1.1300 -73.05%
on 04/17/20
+0.2127 (+231.70%)
since 02/27/20

Most Recent Stories

More News
Hollister Biosciences Inc. Announces Filing of Amended and Restated Interim Financial Statements and MD&A for the Three and Nine Months Ended September 30, 2020.

Hollister Biosciences Inc. Announces Filing of Amended and Restated Interim Financial Statements and MD&A for the Three and Nine Months Ended September 30, 2020.

HOLL.CN : 0.390 (+2.63%)
HSTRF : 0.3045 (-0.75%)
Research and Development Moves the Psychedelics Market Forward

, /PRNewswire/ -- The ongoing surge of development and investment into psychedelic medicine and psychedelic-assisted therapy is the direct result of newfound public support and legitimacy for these revolutionary...

MYCO.CN : 0.455 (-4.21%)
NUMI.VN : 1.400 (-7.28%)
LKYSF : 1.1100 (-8.26%)
TNXP : 1.1300 (-7.38%)
HSTRF : 0.3045 (-0.75%)
MMEDF : 3.2900 (-6.00%)
Hollister Biosciences Inc. Commends the State of Arizona for starting Adult-Use Cannabis Sales ahead of schedule, Venom Extracts it's 100% owned subsidiary is a category leader with over 4 million grams sold throughout the state in 2020

Hollister Biosciences Inc. Commends the State of Arizona for starting Adult-Use Cannabis Sales ahead of schedule, Venom Extracts it's 100% owned subsidiary is a category leader with over 4 million grams...

HOLL.CN : 0.390 (+2.63%)
HSTRF : 0.3045 (-0.75%)
Hollister Biosciences Inc. Commends the State of Arizona for starting Adult-Use Cannabis Sales ahead of schedule, Venom Extracts it's 100% owned subsidiary is a category leader with over 4 million grams sold throughout the state in 2020

VANCOUVER, BC , Jan. 25, 2021 /PRNewswire/ -  Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the " Company ", " Hollister Cannabis Co ." or " Hollister ")...

HSTRF : 0.3045 (-0.75%)
HOLL : 0.2498 (-16.73%)
/C O R R E C T I O N from Source -- Hollister Biosciences Inc./

In the news release, Hollister Biosciences Inc. Provides Update on Q4 2020 Performance Including CDN in Revenue With an Estimated CDN in EBITDA a YoY Revenue Increase of 3215% from Q4 2019, issued by...

HOLL.CN : 0.390 (+2.63%)
HSTRF : 0.3045 (-0.75%)
Hollister Biosciences Inc. Provides Update on Q4 2020 Performance Including CDN $14.93 Million in Revenue With an Estimated CDN $5.53 Million in EBITDA a YoY Revenue Increase of 3215% from Q4 2019

, /PRNewswire/ - (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the "", "." or "") a diversified cannabis branding company with products in over 280 dispensaries throughout , and over 90 dispensaries throughout...

HOLL.CN : 0.390 (+2.63%)
HSTRF : 0.3045 (-0.75%)
Hollister Biosciences Inc. Provides Update on Q4 2020 Performance Including CDN $14.93 Million in Revenue With an Estimated CDN $5.53 Million in EBITDA a YoY Revenue Increase of 3215% from Q4 2019

VANCOUVER, BC , Jan. 7, 2021 /PRNewswire/ - Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the " Company ", " Hollister Cannabis Co ." or " Hollister ...

HSTRF : 0.3045 (-0.75%)
HOLL : 0.2498 (-16.73%)
Further Research into Psilocybin Opens New Doors for Treatment

, /PRNewswire/ -- Among the popular fields of study for biotech companies in recent years are gene editing, tissue engineering and regeneration, nanobiotechnology and others. In addition, new segments...

MYCOF : 0.3578 (-5.47%)
MYCO.CN : 0.455 (-4.21%)
LLY : 202.00 (-1.05%)
RVVTF : 0.3360 (-9.16%)
HSTRF : 0.3045 (-0.75%)
TNXP : 1.1300 (-7.38%)
Hollister Biosciences Inc.'s Direct to Consumer Cannabis Delivery Platform, Dreamy Delivery Launches 2nd Depot in Sacramento, California

, /PRNewswire/ - Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the "", "" or "") a diversified cannabis branding company with products in over 280 dispensaries throughout , and...

HOLL.CN : 0.390 (+2.63%)
HSTRF : 0.3045 (-0.75%)
Hollister Biosciences Inc.'s Direct to Consumer Cannabis Delivery Platform, Dreamy Delivery Launches 2nd Depot in Sacramento, California

VANCOUVER, BC , Dec. 22, 2020 /PRNewswire/ - Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the " Company ", " Hollister Cannabis Co. " or " Hollister ")...

HSTRF : 0.3045 (-0.75%)
HOLL : 0.2498 (-16.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.3396
2nd Resistance Point 0.3286
1st Resistance Point 0.3166
Last Price 0.3045
1st Support Level 0.2936
2nd Support Level 0.2826
3rd Support Level 0.2706

See More

52-Week High 1.1300
Fibonacci 61.8% 0.7079
Fibonacci 50% 0.5775
Fibonacci 38.2% 0.4471
Last Price 0.3045
52-Week Low 0.0250

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar